Skip to content

New research, once a week

The week's new whitepapers in one short email.

You can stop at any time on the Opt-Out page.

AstraNu Closes $3.5 Million Seed Round Led by Celesta Capital to Commercialize Chip-Scale Optical Imaging Engine

AstraNu, developer of the first chip-scale optical coherence tomography (OCT) imaging engine for the medical device industry, today announced it has closed $3.5 million in seed funding. The round was led by Celesta…

AstraNu17 November 20263 min read

  • Round includes co-investment from the New Jersey Innovation Evergreen Fund
  • Nokia Bell Labs spin-out will move its imaging engine into partner medical device applications

MURRAY HILL, N.J., Nov. 17, 2026 /PRNewswire/ -- AstraNu, developer of the first chip-scale optical coherence tomography (OCT) imaging engine for the medical device industry, today announced it has closed $3.5 million in seed funding. The round was led by Celesta Capital, with co-investment from the New Jersey Innovation Evergreen Fund (NJIEF), a program of the New Jersey Economic Development Authority (NJEDA).

AstraNu spun out of Nokia Bell Labs in May 2025 with backing from Celesta, the first venture in the two companies' collaboration to commercialize Bell Labs technologies. The company has since achieved swept-source OCT performance at chip scale and is ready to demonstrate and validate it with application partners.

AstraNu will use the funding to build its photonics development team, validate the performance of its engine, and prepare for volume manufacturing.

"This funding enables us to drive our strategy forward by building out our photonics development team and manufacturing readiness ahead of customer volume," said Kevin Blalock, President and General Manager of AstraNu. "Celesta's backing, together with the NJIEF's support, gives us the runway to get our engine into partner testbeds and validate the performance we have achieved."

Swept-source OCT (SS-OCT) can deliver faster, deeper imaging than legacy spectral-domain OCT (SD-OCT), but to date its cost and size have limited the reach of its applications. Developed at Nokia Bell Labs, AstraNu's engine delivers SS-OCT imaging performance at SD-OCT price points – delivering a module more than 10x smaller and significantly lower in cost than conventional swept-source systems. The company supplies this imaging engine to established medical device, imaging, and optics companies looking to integrate high-performance OCT into their own products. Ophthalmology, the largest current market for the technology, is its initial commercial focus, and the company is also working with developers of applications in ENT, urology, and oncology, among others.

"AstraNu is an outstanding example of where we invest: foundational technology from one of the world's leading research labs, with the potential to change what is possible in a large and established market," said Matthew Marsh, Managing Partner and CFO of Celesta Capital. "By delivering a new cost and performance package, AstraNu is opening this imaging technology to entirely new applications and markets. Scaling a technology like this from the lab into volume production requires disciplined operations and commercial partners – supporting founders in this work is what we do. Celesta is delighted to lead this round alongside NJEDA, and to continue our partnership with Nokia to build globally competitive companies around market-shifting technologies."

Medical device, imaging and optics companies interested in evaluating the engine can contact AstraNu at info@astranu.com.

About AstraNu, Inc.

AstraNu develops a chip-scale optical coherence tomography imaging engine that gives medical device manufacturers swept-source performance at a fraction of the size and cost of conventional systems – enabling high-performance imaging in new products and new clinical applications.. The company spun out of Nokia Bell Labs in 2025 and is headquartered in Murray Hill, New Jersey. For more information, visit astranu.com.

About Celesta Capital

Celesta Capital is a venture capital firm built by global deep tech operators. Since 2013, we've backed the foundational technologies that unlock every major technology wave: semiconductors and intelligent hardware, bio-convergence, and industry transformers. Founded by Silicon Valley veterans who've built, scaled, and exited major global technology companies, today we bring that operating experience to support deep tech founders from breakthrough to global scale. For more information, visit www.celesta.vc.

Media Contact:

Kevin Blalock
Kevin@AstraNu.com

Cision View original content:https://www.prnewswire.com/news-releases/astranu-closes-3-5-million-seed-round-led-by-celesta-capital-to-commercialize-chip-scale-optical-imaging-engine-302941615.html

SOURCE AstraNu

Found this useful? Share it

New research, once a week

The week's new whitepapers in one short email.